应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
KTTA Pasithea Therapeutics Corp.
盘后交易 07-14 16:37:11 EDT
0.6900
+0.0007
+0.10%
盘后
0.6900
+0.0000
0.00%
16:04 EDT
最高
0.6900
最低
0.6680
成交量
6.33万
今开
0.6893
昨收
0.6893
日振幅
3.19%
总市值
513.61万
流通市值
466.37万
总股本
744.36万
成交额
4.29万
换手率
0.94%
流通股本
675.90万
市净率
0.40
ROE
-82.81%
每股收益
-9.80
52周最高
7.50
52周最低
0.6680
市盈率
-0.07
股息
0.00
股息收益率
0.00
ROA
-46.84%
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Pasithea Therapeutics Corp.5月29日成交额为18.69万美元
市场透视 · 05-30
Pasithea Therapeutics Corp.5月29日成交额为18.69万美元
Pasithea Therapeutics Corp.5月23日成交额为22.66万美元
市场透视 · 05-24
Pasithea Therapeutics Corp.5月23日成交额为22.66万美元
Pasithea Therapeutics Corp.5月21日成交额为54.44万美元
市场透视 · 05-22
Pasithea Therapeutics Corp.5月21日成交额为54.44万美元
Pasithea Therapeutics Corp.5月20日成交额为1403.79万美元
市场透视 · 05-21
Pasithea Therapeutics Corp.5月20日成交额为1403.79万美元
Pasithea Therapeutics Corp.5月19日成交额为47.21万美元
市场透视 · 05-20
Pasithea Therapeutics Corp.5月19日成交额为47.21万美元
Forte Biosciences, Inc.盘中异动 股价大涨10.73%报8.67美元
市场透视 · 05-16
Forte Biosciences, Inc.盘中异动 股价大涨10.73%报8.67美元
Pasithea Therapeutics Corp.5月15日成交额为110.19万美元
市场透视 · 05-16
Pasithea Therapeutics Corp.5月15日成交额为110.19万美元
Pasithea Therapeutics(KTTA.US):2025年Q1财报实现营收0美元,前值为0美元;每股收益为-1.61美元,前值为-3.70美元。
金融界 · 05-15
Pasithea Therapeutics(KTTA.US):2025年Q1财报实现营收0美元,前值为0美元;每股收益为-1.61美元,前值为-3.70美元。
Pasithea Therapeutics Corp.5月14日成交额为1432.17万美元
市场透视 · 05-15
Pasithea Therapeutics Corp.5月14日成交额为1432.17万美元
Pasithea Therapeutics Corp.5月13日成交额为65.57万美元
市场透视 · 05-14
Pasithea Therapeutics Corp.5月13日成交额为65.57万美元
Pasithea Therapeutics Corp.5月8日成交额为229.25万美元
市场透视 · 05-09
Pasithea Therapeutics Corp.5月8日成交额为229.25万美元
万春医药盘中异动 急速拉升20.66%报2.02美元
市场透视 · 05-06
万春医药盘中异动 急速拉升20.66%报2.02美元
Catalyst Pharmaceuticals, Inc.盘中异动 股价大跌5.02%报23.08美元
市场透视 · 05-06
Catalyst Pharmaceuticals, Inc.盘中异动 股价大跌5.02%报23.08美元
Absci Corporation盘中异动 急速下挫5.23%报2.72美元
市场透视 · 05-06
Absci Corporation盘中异动 急速下挫5.23%报2.72美元
Arcellx, Inc.盘中异动 急速下挫5.01%
市场透视 · 05-06
Arcellx, Inc.盘中异动 急速下挫5.01%
Hcw Biologics Inc.盘中异动 股价大跌7.11%报6.53美元
市场透视 · 05-06
Hcw Biologics Inc.盘中异动 股价大跌7.11%报6.53美元
Abvc Biopharma, Inc.盘中异动 股价大涨5.31%报1.18美元
市场透视 · 05-06
Abvc Biopharma, Inc.盘中异动 股价大涨5.31%报1.18美元
珐博进盘中异动 股价大跌5.06%报0.302美元
市场透视 · 05-06
珐博进盘中异动 股价大跌5.06%报0.302美元
Immunocore Hldgs Plc盘中异动 股价大跌5.13%
市场透视 · 05-06
Immunocore Hldgs Plc盘中异动 股价大跌5.13%
Barinthus Biotherapeutics Plc盘中异动 急速上涨5.21%报1.010美元
市场透视 · 05-06
Barinthus Biotherapeutics Plc盘中异动 急速上涨5.21%报1.010美元
加载更多
公司概况
公司名称:
Pasithea Therapeutics Corp.
所属市场:
NASDAQ
上市日期:
2021-08-11
主营业务:
Pasithea Therapeutics Corp.于2020年5月12日在特拉华州成立。该公司从事有关CNS疾病的精神病学和神经病学研究,目标是将该研究转化为可用于临床的药物。
发行价格:
4.99
{"stockData":{"symbol":"KTTA","market":"US","secType":"STK","nameCN":"Pasithea Therapeutics Corp.","latestPrice":0.69,"timestamp":1752523200000,"preClose":0.6893,"halted":0,"volume":63271,"hourTrading":{"tag":"盘后","latestPrice":0.69,"preClose":0.69,"latestTime":"16:04 EDT","volume":26,"amount":17.939999999999998,"timestamp":1752523455270},"delay":0,"floatShares":6759041,"shares":7443577,"eps":-9.801436,"marketStatus":"盘后交易","change":0.0007,"latestTime":"07-14 16:37:09 EDT","open":0.6893,"high":0.69,"low":0.668,"amount":42929.52535,"amplitude":0.031916,"askPrice":0.7,"askSize":400,"bidPrice":0.65,"bidSize":30,"shortable":3,"etf":0,"ttmEps":-9.801436,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1752537600000},"marketStatusCode":4,"adr":0,"listingDate":1628654400000,"exchange":"NASDAQ","adjPreClose":0.6893,"preHourTrading":{"tag":"盘前","latestPrice":0.692,"preClose":0.6893,"latestTime":"08:00 EDT","volume":452,"amount":315.7867716,"timestamp":1752494402281},"postHourTrading":{"tag":"盘后","latestPrice":0.69,"preClose":0.69,"latestTime":"16:04 EDT","volume":26,"amount":17.939999999999998,"timestamp":1752523455270},"volumeRatio":0.757537},"requestUrl":"/m/hq/s/KTTA","defaultTab":"news","newsList":[{"id":"2539621934","title":"Pasithea Therapeutics Corp.5月29日成交额为18.69万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2539621934","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539621934?lang=zh_cn&edition=full","pubTime":"2025-05-30 10:36","pubTimestamp":1748572566,"startTime":"0","endTime":"0","summary":"美东时间2025年5月29日,Pasithea Therapeutics Corp.成交额为18.69万美元,成交额较昨日减少63.05%,当日成交量为20.32万股。Pasithea Therapeutics Corp.于2025年5月29日涨4.96%,报0.94美元,该股过去5个交易日涨0.97%,年初至今跌70.16%,过去60日跌12.96%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-05-29|18.69万|-63.05%|20.32万|#|2025-05-28|50.58万|25.25%|59.24万|#|2025-05-27|40.38万|78.17%|44.49万|#|2025-05-23|22.66万|-33.13%|24.57万|#|2025-05-22|33.90万|-37.74%|36.63万|Pasithea Therapeutics Corp是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530103612a4922101&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530103612a4922101&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KTTA","BK4007","BK4539","LENZ"],"gpt_icon":0},{"id":"2537169327","title":"Pasithea Therapeutics Corp.5月23日成交额为22.66万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537169327","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537169327?lang=zh_cn&edition=full","pubTime":"2025-05-24 10:22","pubTimestamp":1748053346,"startTime":"0","endTime":"0","summary":"美东时间2025年5月23日,Pasithea Therapeutics Corp.成交额为22.66万美元,成交额较昨日减少33.13%,当日成交量为24.57万股。Pasithea Therapeutics Corp.于2025年5月23日跌2.73%,报0.915美元,该股过去5个交易日跌4.26%,年初至今跌70.94%,过去60日跌24.98%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-05-23|22.66万|-33.13%|24.57万|#|2025-05-22|33.90万|-37.74%|36.63万|#|2025-05-21|54.44万|-96.12%|58.32万|#|2025-05-20|1403.79万|2873.32%|1460.87万|#|2025-05-19|47.21万|-94.01%|50.99万|Pasithea Therapeutics Corp是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250524102227a48a584c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250524102227a48a584c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","BK4007","LENZ","KTTA"],"gpt_icon":0},{"id":"2537648639","title":"Pasithea Therapeutics Corp.5月21日成交额为54.44万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537648639","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537648639?lang=zh_cn&edition=full","pubTime":"2025-05-22 10:24","pubTimestamp":1747880688,"startTime":"0","endTime":"0","summary":"美东时间2025年5月21日,Pasithea Therapeutics Corp.成交额为54.44万美元,成交额较昨日减少96.12%,当日成交量为58.32万股。Pasithea Therapeutics Corp.于2025年5月21日跌4.73%,报0.931美元,该股过去5个交易日跌2.49%,年初至今跌70.44%,过去60日跌19.03%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-05-21|54.44万|-96.12%|58.32万|#|2025-05-20|1403.79万|2873.32%|1460.87万|#|2025-05-19|47.21万|-94.01%|50.99万|#|2025-05-16|788.12万|615.25%|763.63万|#|2025-05-15|110.19万|-92.31%|121.09万|Pasithea Therapeutics Corp是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522102458a4878af8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522102458a4878af8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LENZ","BK4539","KTTA"],"gpt_icon":0},{"id":"2537676391","title":"Pasithea Therapeutics Corp.5月20日成交额为1403.79万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537676391","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537676391?lang=zh_cn&edition=full","pubTime":"2025-05-21 10:23","pubTimestamp":1747794198,"startTime":"0","endTime":"0","summary":"美东时间2025年5月20日,Pasithea Therapeutics Corp.成交额为1403.79万美元,成交额较昨日增加2873.32%,当日成交量为1460.87万股。Pasithea Therapeutics Corp.于2025年5月20日涨3.77%,报0.977美元,该股过去5个交易日涨13.65%,年初至今跌68.97%,过去60日跌22.43%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-05-20|1403.79万|2873.32%|1460.87万|#|2025-05-19|47.21万|-94.01%|50.99万|#|2025-05-16|788.12万|615.25%|763.63万|#|2025-05-15|110.19万|-92.31%|121.09万|#|2025-05-14|1432.17万|2084.17%|1473.90万|Pasithea Therapeutics Corp是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521102322a6e6bc78&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521102322a6e6bc78&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","BK4007","LENZ","KTTA"],"gpt_icon":0},{"id":"2536650732","title":"Pasithea Therapeutics Corp.5月19日成交额为47.21万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536650732","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536650732?lang=zh_cn&edition=full","pubTime":"2025-05-20 10:16","pubTimestamp":1747707367,"startTime":"0","endTime":"0","summary":"美东时间2025年5月19日,Pasithea Therapeutics Corp.成交额为47.21万美元,成交额较昨日减少94.01%,当日成交量为50.99万股。Pasithea Therapeutics Corp.于2025年5月19日跌1.47%,报0.942美元,该股过去5个交易日涨8.26%,年初至今跌70.1%,过去60日跌27.55%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-05-19|47.21万|-94.01%|50.99万|#|2025-05-16|788.12万|615.25%|763.63万|#|2025-05-15|110.19万|-92.31%|121.09万|#|2025-05-14|1432.17万|2084.17%|1473.90万|#|2025-05-13|65.57万|-26.95%|73.68万|Pasithea Therapeutics Corp是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520101616a6e569d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520101616a6e569d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","KTTA","LENZ","BK4139","BK4007"],"gpt_icon":0},{"id":"2535298315","title":"Forte Biosciences, Inc.盘中异动 股价大涨10.73%报8.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535298315","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535298315?lang=zh_cn&edition=full","pubTime":"2025-05-16 21:36","pubTimestamp":1747402571,"startTime":"0","endTime":"0","summary":"北京时间2025年05月16日21时36分,Forte Biosciences, Inc.股票出现异动,股价急速拉升10.73%。截至发稿,该股报8.67美元/股,成交量1473股,换手率0.02%,振幅0.13%。Forte Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为0.34%。Forte Biosciences, Inc.公司简介:Forte Biosciences Inc 是一家生物制药公司,正在通过临床前试验推进其候选产品 FB-102 的研发,这是一种专有的治疗分子,在移植物抗宿主病,白癜风和斑秃和1型糖尿病等适应症方面具有广泛的自身免疫应用。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516213612975bd99a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516213612975bd99a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FBRX","KTTA","BK4139"],"gpt_icon":0},{"id":"2535382642","title":"Pasithea Therapeutics Corp.5月15日成交额为110.19万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535382642","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535382642?lang=zh_cn&edition=full","pubTime":"2025-05-16 10:17","pubTimestamp":1747361828,"startTime":"0","endTime":"0","summary":"美东时间2025年5月15日,Pasithea Therapeutics Corp.成交额为110.19万美元,成交额较昨日减少92.31%,当日成交量为121.09万股。Pasithea Therapeutics Corp.于2025年5月15日跌9.9%,报0.861美元,该股过去5个交易日跌10.35%,年初至今跌72.68%,过去60日跌32.77%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-05-15|110.19万|-92.31%|121.09万|#|2025-05-14|1432.17万|2084.17%|1473.90万|#|2025-05-13|65.57万|-26.95%|73.68万|#|2025-05-12|89.76万|-49.15%|104.18万|#|2025-05-09|176.51万|-23.00%|206.25万|Pasithea Therapeutics Corp是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516101716a6e10fb8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516101716a6e10fb8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","KTTA","BK4007","BK4539","BK4139"],"gpt_icon":0},{"id":"2535801300","title":"Pasithea Therapeutics(KTTA.US):2025年Q1财报实现营收0美元,前值为0美元;每股收益为-1.61美元,前值为-3.70美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2535801300","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535801300?lang=zh_cn&edition=full","pubTime":"2025-05-16 06:42","pubTimestamp":1747348944,"startTime":"0","endTime":"0","summary":"Pasithea Therapeutics(KTTA.US):2025年Q1财报实现营收0美元,前值为0美元;每股收益为-1.61美元,前值为-3.70美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/16064250430301.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["KTTA","LENZ"],"gpt_icon":0},{"id":"2535830704","title":"Pasithea Therapeutics Corp.5月14日成交额为1432.17万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535830704","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535830704?lang=zh_cn&edition=full","pubTime":"2025-05-15 10:10","pubTimestamp":1747275041,"startTime":"0","endTime":"0","summary":"美东时间2025年5月14日,Pasithea Therapeutics Corp.成交额为1432.17万美元,成交额较昨日增加2084.17%,当日成交量为1473.90万股。Pasithea Therapeutics Corp.于2025年5月14日涨11.07%,报0.955美元,该股过去5个交易日跌15.47%,年初至今跌69.68%,过去60日跌30.28%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-05-14|1432.17万|2084.17%|1473.90万|#|2025-05-13|65.57万|-26.95%|73.68万|#|2025-05-12|89.76万|-49.15%|104.18万|#|2025-05-09|176.51万|-23.00%|206.25万|#|2025-05-08|229.25万|-54.29%|226.30万|Pasithea Therapeutics Corp是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515101050a47ee73d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515101050a47ee73d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","KTTA","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2535528500","title":"Pasithea Therapeutics Corp.5月13日成交额为65.57万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535528500","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535528500?lang=zh_cn&edition=full","pubTime":"2025-05-14 10:09","pubTimestamp":1747188568,"startTime":"0","endTime":"0","summary":"美东时间2025年5月13日,Pasithea Therapeutics Corp.成交额为65.57万美元,成交额较昨日减少26.95%,当日成交量为73.68万股。Pasithea Therapeutics Corp.于2025年5月13日跌1.15%,报0.86美元,该股过去5个交易日跌43.42%,年初至今跌72.7%,过去60日跌40.69%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-05-13|65.57万|-26.95%|73.68万|#|2025-05-12|89.76万|-49.15%|104.18万|#|2025-05-09|176.51万|-23.00%|206.25万|#|2025-05-08|229.25万|-54.29%|226.30万|#|2025-05-07|501.48万|-99.22%|428.62万|Pasithea Therapeutics Corp是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514100935a6de45b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514100935a6de45b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4539","BK4139","KTTA"],"gpt_icon":0},{"id":"2534116146","title":"Pasithea Therapeutics Corp.5月8日成交额为229.25万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534116146","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534116146?lang=zh_cn&edition=full","pubTime":"2025-05-09 09:55","pubTimestamp":1746755738,"startTime":"0","endTime":"0","summary":"美东时间2025年5月8日,Pasithea Therapeutics Corp.成交额为229.25万美元,成交额较昨日减少54.29%,当日成交量为226.30万股。Pasithea Therapeutics Corp.于2025年5月8日跌15.04%,报0.96美元,该股过去5个交易日跌36.84%,年初至今跌69.52%,过去60日跌31.91%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-05-08|229.25万|-54.29%|226.30万|#|2025-05-07|501.48万|-99.22%|428.62万|#|2025-05-06|6.40亿|305931.76%|2.26亿|#|2025-05-05|20.93万|-21.66%|14.89万|#|2025-05-02|26.71万|-42.89%|18.36万|Pasithea Therapeutics Corp 是一家生物技术公司。该公司专注于发现、研究和开发中枢神经系统 疾病和其他疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509095546a4777a04&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509095546a4777a04&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","KTTA","BK4139","BK4007","BK4539"],"gpt_icon":0},{"id":"2533616686","title":"万春医药盘中异动 急速拉升20.66%报2.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533616686","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533616686?lang=zh_cn&edition=full","pubTime":"2025-05-07 03:41","pubTimestamp":1746560513,"startTime":"0","endTime":"0","summary":"北京时间2025年05月07日03时41分,万春医药股票出现波动,股价急速拉升20.66%。截至发稿,该股报2.02美元/股,成交量1.4084万股,换手率0.03%,振幅2.69%。万春医药股票所在的生物技术行业中,整体跌幅为5.59%。万春医药公司简介:BeyondSpring Inc 从事临床阶段的生物制药活动,重点是开发癌症疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050703415397510020&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050703415397510020&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BYSI","KTTA","BK4139"],"gpt_icon":0},{"id":"2533505966","title":"Catalyst Pharmaceuticals, Inc.盘中异动 股价大跌5.02%报23.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533505966","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533505966?lang=zh_cn&edition=full","pubTime":"2025-05-07 01:13","pubTimestamp":1746551603,"startTime":"0","endTime":"0","summary":"北京时间2025年05月07日01时13分,Catalyst Pharmaceuticals, Inc.股票出现波动,股价急速下挫5.02%。截至发稿,该股报23.08美元/股,成交量44.9297万股,换手率0.37%,振幅4.44%。Catalyst Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为5.70%。其相关个股中,Liminatus Pharma Inc C/Wts 30/04/2030 、Sol-Gel Technologies Ltd.、Protagenic Therapeutics Inc C/Wts 26/04/2026 涨幅较大,Pasithea Therapeutics Corp.、Galmed Pharmaceuticals Ltd.、Nucana Plc较为活跃,换手率分别为8069.40%、1204.69%、515.52%,振幅较大的相关个股有Pasithea Therapeutics Corp.、Celularity Inc C/Wts 16/07/2026 、Protagenic Therapeutics, Inc.,振幅分别为162.68%、69.05%、47.02%。Catalyst Pharmaceuticals, Inc.公司简介:Catalyst Pharmaceuticals Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505070113239750e8c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505070113239750e8c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CPRX","KTTA","IE00B19Z6F94.USD","BK4139","IE0034390439.USD"],"gpt_icon":0},{"id":"2533142657","title":"Absci Corporation盘中异动 急速下挫5.23%报2.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533142657","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533142657?lang=zh_cn&edition=full","pubTime":"2025-05-07 00:43","pubTimestamp":1746549835,"startTime":"0","endTime":"0","summary":"北京时间2025年05月07日00时43分,Absci Corporation股票出现异动,股价大幅跳水5.23%。截至发稿,该股报2.72美元/股,成交量111.427万股,换手率0.87%,振幅3.86%。Absci Corporation股票所在的生物技术行业中,整体跌幅为5.17%。其相关个股中,Liminatus Pharma Inc C/Wts 30/04/2030 、Celularity Inc C/Wts 16/07/2026 、Sol-Gel Technologies Ltd.涨幅较大,Pasithea Therapeutics Corp.、Galmed Pharmaceuticals Ltd.、Nucana Plc较为活跃,换手率分别为7923.96%、1200.29%、499.89%,振幅较大的相关个股有Pasithea Therapeutics Corp.、Liminatus Pharma Inc C/Wts 30/04/2030 、Polyrizon Ltd.,振幅分别为158.45%、42.31%、40.65%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507004355a4744111&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507004355a4744111&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KTTA","ABSI","BK4139","BK4121","BK4539"],"gpt_icon":0},{"id":"2533505826","title":"Arcellx, Inc.盘中异动 急速下挫5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533505826","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533505826?lang=zh_cn&edition=full","pubTime":"2025-05-07 00:42","pubTimestamp":1746549743,"startTime":"0","endTime":"0","summary":"北京时间2025年05月07日00时42分,Arcellx, Inc.股票出现波动,股价急速跳水5.01%。Arcellx, Inc.股票所在的生物技术行业中,整体跌幅为5.09%。其相关个股中,Liminatus Pharma Inc C/Wts 30/04/2030 、Celularity Inc C/Wts 16/07/2026 、Sol-Gel Technologies Ltd.涨幅较大,Pasithea Therapeutics Corp.、Galmed Pharmaceuticals Ltd.、Nucana Plc较为活跃,换手率分别为7920.67%、1200.27%、499.39%,振幅较大的相关个股有Pasithea Therapeutics Corp.、Liminatus Pharma Inc C/Wts 30/04/2030 、Polyrizon Ltd.,振幅分别为158.45%、42.31%、40.65%。Arcellx, Inc.公司简介:Arcellx Inc是一家临床阶段的生物技术公司,通过开发针对癌症和其他不治之症患者的免疫疗法,重新构思细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505070042239750e436&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505070042239750e436&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACLX","BK4139","KTTA"],"gpt_icon":0},{"id":"2533522496","title":"Hcw Biologics Inc.盘中异动 股价大跌7.11%报6.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533522496","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533522496?lang=zh_cn&edition=full","pubTime":"2025-05-07 00:28","pubTimestamp":1746548895,"startTime":"0","endTime":"0","summary":"北京时间2025年05月07日00时28分,Hcw Biologics Inc.股票出现异动,股价快速下挫7.11%。截至发稿,该股报6.53美元/股,成交量3815股,换手率0.34%,振幅1.64%。Hcw Biologics Inc.股票所在的生物技术行业中,整体跌幅为5.04%。Hcw Biologics Inc.公司简介:HCW Biologics Inc是一家临床阶段的生物制药公司,专注于发现和开发新型免疫疗法,通过打破慢性低度炎症与与年龄相关疾病之间的联系,延长健康寿命。它已选择了两种分子作为其产品候选药物;HCW9218和HCW9302。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505070028159750e1fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505070028159750e1fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","KTTA","HCWB","BK4139"],"gpt_icon":0},{"id":"2533654212","title":"Abvc Biopharma, Inc.盘中异动 股价大涨5.31%报1.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533654212","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533654212?lang=zh_cn&edition=full","pubTime":"2025-05-07 00:17","pubTimestamp":1746548261,"startTime":"0","endTime":"0","summary":"北京时间2025年05月07日00时17分,Abvc Biopharma, Inc.股票出现异动,股价急速拉升5.31%。截至发稿,该股报1.18美元/股,成交量6.8432万股,换手率0.43%,振幅4.46%。Abvc Biopharma, Inc.股票所在的生物技术行业中,整体跌幅为4.82%。Abvc Biopharma, Inc.公司简介:ABVC BioPharma Inc 是一家临床阶段生物制药公司,目前正在开发六种药物和一种医疗器械。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507001741a4743a26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507001741a4743a26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KTTA","ABVC"],"gpt_icon":0},{"id":"2533654756","title":"珐博进盘中异动 股价大跌5.06%报0.302美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533654756","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533654756?lang=zh_cn&edition=full","pubTime":"2025-05-07 00:16","pubTimestamp":1746548213,"startTime":"0","endTime":"0","summary":"北京时间2025年05月07日00时16分,珐博进股票出现异动,股价快速下跌5.06%。截至发稿,该股报0.302美元/股,成交量18.6018万股,换手率0.18%,振幅5.28%。机构评级方面,在所有2家参与评级的机构中,50%的券商给予买入建议,50%的券商给予持有建议,无券商给予卖出建议。珐博进股票所在的生物技术行业中,整体跌幅为4.73%。迄今为止,珐博进几乎所有的收入都来自其合作协议。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507001653a47439f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507001653a47439f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KTTA","BK4139","BK4505","FGEN"],"gpt_icon":0},{"id":"2533654718","title":"Immunocore Hldgs Plc盘中异动 股价大跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533654718","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533654718?lang=zh_cn&edition=full","pubTime":"2025-05-07 00:10","pubTimestamp":1746547849,"startTime":"0","endTime":"0","summary":"北京时间2025年05月07日00时10分,Immunocore Hldgs Plc股票出现异动,股价快速跳水5.13%。Immunocore Hldgs Plc股票所在的生物技术行业中,整体跌幅为4.98%。其相关个股中,Celularity Inc C/Wts 16/07/2026 、Sol-Gel Technologies Ltd.、Tiziana Life Sciences Ltd涨幅较大,Pasithea Therapeutics Corp.、Galmed Pharmaceuticals Ltd.、Nucana Plc较为活跃,换手率分别为7830.80%、1188.90%、482.03%,振幅较大的相关个股有Pasithea Therapeutics Corp.、Liminatus Pharma Inc C/Wts 30/04/2030 、Pasithea Therapeutics Corp C/Wts 12/08/2026 ,振幅分别为158.45%、42.31%、40.32%。Immunocore Hldgs Plc公司简介:Immunocore Holdings PLC是一家商业阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507001049aa2c84c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507001049aa2c84c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KTTA","BK4505","IMCR"],"gpt_icon":0},{"id":"2533654227","title":"Barinthus Biotherapeutics Plc盘中异动 急速上涨5.21%报1.010美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533654227","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533654227?lang=zh_cn&edition=full","pubTime":"2025-05-07 00:00","pubTimestamp":1746547204,"startTime":"0","endTime":"0","summary":"北京时间2025年05月07日00时00分,Barinthus Biotherapeutics Plc股票出现异动,股价急速上涨5.21%。Barinthus Biotherapeutics Plc股票所在的生物技术行业中,整体跌幅为4.88%。Barinthus Biotherapeutics Plc公司简介:Barinthus Biotherapeutics PLC 是一家临床阶段的生物制药公司,开发新型 T 细胞免疫疗法,指导免疫系统克服慢性传染病、自身免疫和癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050700000594ee2a3f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050700000594ee2a3f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BRNS","KTTA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.pasithea.com","stockEarnings":[{"period":"1week","weight":-0.0586},{"period":"1month","weight":-0.1881},{"period":"3month","weight":-0.5146},{"period":"6month","weight":-0.7307},{"period":"1year","weight":-0.8687},{"period":"ytd","weight":-0.7812}],"compareEarnings":[{"period":"1week","weight":-0.0028},{"period":"1month","weight":0.037},{"period":"3month","weight":0.168},{"period":"6month","weight":0.0743},{"period":"1year","weight":0.1207},{"period":"ytd","weight":0.0641}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Pasithea Therapeutics Corp.于2020年5月12日在特拉华州成立。该公司从事有关CNS疾病的精神病学和神经病学研究,目标是将该研究转化为可用于临床的药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.144911},{"month":2,"riseRate":0.25,"avgChangeRate":-0.196749},{"month":3,"riseRate":0.5,"avgChangeRate":0.020643},{"month":4,"riseRate":0.25,"avgChangeRate":0.021877},{"month":5,"riseRate":0.25,"avgChangeRate":-0.227944},{"month":6,"riseRate":0.5,"avgChangeRate":0.06208},{"month":7,"riseRate":0.75,"avgChangeRate":0.090542},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.043118},{"month":9,"riseRate":0.666667,"avgChangeRate":0.026262},{"month":10,"riseRate":0,"avgChangeRate":-0.193548},{"month":11,"riseRate":0.25,"avgChangeRate":-0.017571},{"month":12,"riseRate":0.5,"avgChangeRate":-0.176814}],"exchange":"NASDAQ","name":"Pasithea Therapeutics Corp.","nameEN":"Pasithea Therapeutics Corp."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Pasithea Therapeutics Corp.(KTTA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Pasithea Therapeutics Corp.(KTTA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Pasithea Therapeutics Corp.,KTTA,Pasithea Therapeutics Corp.股票,Pasithea Therapeutics Corp.股票老虎,Pasithea Therapeutics Corp.股票老虎国际,Pasithea Therapeutics Corp.行情,Pasithea Therapeutics Corp.股票行情,Pasithea Therapeutics Corp.股价,Pasithea Therapeutics Corp.股市,Pasithea Therapeutics Corp.股票价格,Pasithea Therapeutics Corp.股票交易,Pasithea Therapeutics Corp.股票购买,Pasithea Therapeutics Corp.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Pasithea Therapeutics Corp.(KTTA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Pasithea Therapeutics Corp.(KTTA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}